NCT01475227View on ClinicalTrials.gov

Atazanavir/Ritonavir and Zinc Pharmacokinetic Study

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
HIV Infection
Interventions
DRUG

1 Solvazinc tablet, day 2 to day 15

Zinc sulphate 125mg, day 2 to day 15

DRUG

1 Solvazinc tablet, day 15 to day 28

Zinc sulphate 125mg, day 15 to day 28

Trial Locations (1)

SW10 9NH

St Stephen's AIDS Trust, London

All Listed Sponsors
lead

St Stephens Aids Trust

OTHER

NCT01475227 - Atazanavir/Ritonavir and Zinc Pharmacokinetic Study | Biotech Hunter | Biotech Hunter